Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Warfarin
14 general benefit · 9 not a benefit
Apo-Warfarin · DIN 02242924 · 1 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Warfarin · DIN 02242924
Manufacturer: Apotex Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 1 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Warfarin: Formulary list price $0.08 per unit (the source does not state the unit; exact figure $0.0796). What the ministry pays, not the patient.
Ministry pays: $0.0796 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242924)
Source record
DIN 02242924: Apo-Warfarin
Raw flags: sec3=Y
Item: 201200026; group id 263; item number 0523; lccId None; manufacturer id APX
Source form: Tab; strength: 1mg
Recorded listing: General benefit
Source prices (unrounded): $0.0796; ministry $0.0796
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242924
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66762
Interchangeable products
Coumadin · DIN 01918311 · not recorded
Taro-Warfarin · DIN 02242680 · $0.0796
Shortage status: resolved shortage (ended July 30, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242924
Shortage record checked October 6, 2026
Taro-Warfarin · DIN 02242680 · 1 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Taro-Warfarin · DIN 02242680
Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 1 MG · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTaro-Warfarin: Formulary list price $0.08 per unit (the source does not state the unit; exact figure $0.0796). What the ministry pays, not the patient.
Ministry pays: $0.0796 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242680)
Source record
DIN 02242680: Taro-Warfarin
Raw flags: sec3=Y
Item: 201200026; group id 263; item number 0523; lccId None; manufacturer id TAR
Source form: Tab; strength: 1mg
Recorded listing: General benefit
Source prices (unrounded): $0.0796; ministry $0.0796
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242680
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66470
Interchangeable products
Apo-Warfarin · DIN 02242924 · $0.0796
Coumadin · DIN 01918311 · not recorded
Shortage status: resolved shortage (ended June 30, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242680
Shortage record checked October 6, 2026
Apo-Warfarin · DIN 02242925 · 2 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Warfarin · DIN 02242925
Manufacturer: Apotex Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Warfarin: Formulary list price $0.08 per unit (the source does not state the unit; exact figure $0.0841). What the ministry pays, not the patient.
Ministry pays: $0.0841 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242925)
Source record
DIN 02242925: Apo-Warfarin
Raw flags: sec3=Y
Item: 201200027; group id 263; item number 0524; lccId None; manufacturer id APX
Source form: Tab; strength: 2mg
Recorded listing: General benefit
Source prices (unrounded): $0.0841; ministry $0.0841
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242925
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66763
Interchangeable products
Coumadin · DIN 01918338 · not recorded
Taro-Warfarin · DIN 02242681 · $0.0841
Shortage status: resolved shortage (ended September 25, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242925
Shortage record checked October 6, 2026
Taro-Warfarin · DIN 02242681 · 2 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Taro-Warfarin · DIN 02242681
Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2 MG · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTaro-Warfarin: Formulary list price $0.08 per unit (the source does not state the unit; exact figure $0.0841). What the ministry pays, not the patient.
Ministry pays: $0.0841 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242681)
Source record
DIN 02242681: Taro-Warfarin
Raw flags: sec3=Y
Item: 201200027; group id 263; item number 0524; lccId None; manufacturer id TAR
Source form: Tab; strength: 2mg
Recorded listing: General benefit
Source prices (unrounded): $0.0841; ministry $0.0841
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242681
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66471
Interchangeable products
Apo-Warfarin · DIN 02242925 · $0.0841
Coumadin · DIN 01918338 · not recorded
Shortage status: resolved shortage (ended May 21, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242681
Shortage record checked October 6, 2026
Apo-Warfarin · DIN 02242926 · 2.5 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Warfarin · DIN 02242926
Manufacturer: Apotex Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2.5 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Warfarin: Formulary list price $0.07 per unit (the source does not state the unit; exact figure $0.0674). What the ministry pays, not the patient.
Ministry pays: $0.0674 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242926)
Source record
DIN 02242926: Apo-Warfarin
Raw flags: sec3=Y
Item: 201200010; group id 263; item number 0525; lccId None; manufacturer id APX
Source form: Tab; strength: 2.5mg
Recorded listing: General benefit
Source prices (unrounded): $0.0674; ministry $0.0674
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242926
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66764
Interchangeable products
Coumadin · DIN 01918346 · not recorded
Taro-Warfarin · DIN 02242682 · $0.0674
Shortage status: active shortage (reported May 28, 2024, last updated October 24, 2024) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242926
Shortage record checked October 6, 2026
Taro-Warfarin · DIN 02242682 · 2.5 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Taro-Warfarin · DIN 02242682
Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2.5 MG · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTaro-Warfarin: Formulary list price $0.07 per unit (the source does not state the unit; exact figure $0.0674). What the ministry pays, not the patient.
Ministry pays: $0.0674 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242682)
Source record
DIN 02242682: Taro-Warfarin
Raw flags: sec3=Y
Item: 201200010; group id 263; item number 0525; lccId None; manufacturer id TAR
Source form: Tab; strength: 2.5mg
Recorded listing: General benefit
Source prices (unrounded): $0.0674; ministry $0.0674
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242682
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66472
Interchangeable products
Apo-Warfarin · DIN 02242926 · $0.0674
Coumadin · DIN 01918346 · not recorded
Shortage status: resolved shortage (ended August 4, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242682
Shortage record checked October 6, 2026
Apo-Warfarin · DIN 02245618 · 3 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Warfarin · DIN 02245618
Manufacturer: Apotex Inc.; listing date 2003-01-30
Health Canada: Marketed since 2002-04-23 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 3 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Warfarin: Formulary list price $0.10 per unit (the source does not state the unit; exact figure $0.1043). What the ministry pays, not the patient.
Ministry pays: $0.1043 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245618)
Source record
DIN 02245618: Apo-Warfarin
Raw flags: sec3=Y
Item: 201200062; group id 263; item number 0526; lccId None; manufacturer id APX
Source form: Tab; strength: 3mg
Recorded listing: General benefit
Source prices (unrounded): $0.1043; ministry $0.1043
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245618
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69718
Interchangeable products
Coumadin · DIN 02240205 · not recorded
Taro-Warfarin · DIN 02242683 · $0.1043
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245618
Shortage record checked October 6, 2026
Taro-Warfarin · DIN 02242683 · 3 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Taro-Warfarin · DIN 02242683
Manufacturer: Taro Pharmaceuticals Inc.; listing date 2002-04-04
Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 3 MG · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTaro-Warfarin: Formulary list price $0.10 per unit (the source does not state the unit; exact figure $0.1043). What the ministry pays, not the patient.
Ministry pays: $0.1043 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242683)
Source record
DIN 02242683: Taro-Warfarin
Raw flags: sec3=Y
Item: 201200062; group id 263; item number 0526; lccId None; manufacturer id TAR
Source form: Tab; strength: 3mg
Recorded listing: General benefit
Source prices (unrounded): $0.1043; ministry $0.1043
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242683
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66473
Interchangeable products
Apo-Warfarin · DIN 02245618 · $0.1043
Coumadin · DIN 02240205 · not recorded
Shortage status: discontinued (November 25, 2021, reported by TARO PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242683
Shortage record checked October 6, 2026
Apo-Warfarin · DIN 02242927 · 4 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Warfarin · DIN 02242927
Manufacturer: Apotex Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 4 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Warfarin: Formulary list price $0.10 per unit (the source does not state the unit; exact figure $0.1043). What the ministry pays, not the patient.
Ministry pays: $0.1043 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242927)
Source record
DIN 02242927: Apo-Warfarin
Raw flags: sec3=Y
Item: 201200028; group id 263; item number 0527; lccId None; manufacturer id APX
Source form: Tab; strength: 4mg
Recorded listing: General benefit
Source prices (unrounded): $0.1043; ministry $0.1043
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242927
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66765
Interchangeable products
Coumadin · DIN 02007959 · not recorded
Taro-Warfarin · DIN 02242684 · $0.1043
Shortage status: resolved shortage (ended June 26, 2018); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242927
Shortage record checked October 6, 2026
Taro-Warfarin · DIN 02242684 · 4 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Taro-Warfarin · DIN 02242684
Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 4 MG · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTaro-Warfarin: Formulary list price $0.10 per unit (the source does not state the unit; exact figure $0.1043). What the ministry pays, not the patient.
Ministry pays: $0.1043 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242684)
Source record
DIN 02242684: Taro-Warfarin
Raw flags: sec3=Y
Item: 201200028; group id 263; item number 0527; lccId None; manufacturer id TAR
Source form: Tab; strength: 4mg
Recorded listing: General benefit
Source prices (unrounded): $0.1043; ministry $0.1043
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242684
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66474
Interchangeable products
Apo-Warfarin · DIN 02242927 · $0.1043
Coumadin · DIN 02007959 · not recorded
Shortage status: resolved shortage (ended December 10, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242684
Shortage record checked October 6, 2026
Apo-Warfarin · DIN 02242928 · 5 mg · tablet
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Warfarin · DIN 02242928
Manufacturer: Apotex Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 5 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Warfarin: Formulary list price $0.07 per unit (the source does not state the unit; exact figure $0.0675). What the ministry pays, not the patient.
Ministry pays: $0.0675 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242928)
Source record
DIN 02242928: Apo-Warfarin
Raw flags: sec3=Y
Item: 201200035; group id 263; item number 0528; lccId None; manufacturer id APX
Source form: Tab; strength: 5mg
Recorded listing: General benefit
Source prices (unrounded): $0.0675; ministry $0.0675
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242928
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66766
Interchangeable products
Coumadin · DIN 01918354 · not recorded
Taro-Warfarin · DIN 02242685 · $0.0675
Shortage status: resolved shortage (ended December 24, 2020); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242928
Shortage record checked October 6, 2026
Taro-Warfarin · DIN 02242685 · 5 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Taro-Warfarin · DIN 02242685
Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 5 MG · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTaro-Warfarin: Formulary list price $0.07 per unit (the source does not state the unit; exact figure $0.0675). What the ministry pays, not the patient.
Ministry pays: $0.0675 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242685)
Source record
DIN 02242685: Taro-Warfarin
Raw flags: sec3=Y
Item: 201200035; group id 263; item number 0528; lccId None; manufacturer id TAR
Source form: Tab; strength: 5mg
Recorded listing: General benefit
Source prices (unrounded): $0.0675; ministry $0.0675
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242685
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66475
Interchangeable products
Apo-Warfarin · DIN 02242928 · $0.0675
Coumadin · DIN 01918354 · not recorded
Shortage status: discontinued (September 22, 2023, reported by TARO PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242685
Shortage record checked October 6, 2026
Apo-Warfarin · DIN 02242929 · 10 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Warfarin · DIN 02242929
Manufacturer: Apotex Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 10 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Warfarin: Formulary list price $0.12 per unit (the source does not state the unit; exact figure $0.1211). What the ministry pays, not the patient.
Ministry pays: $0.1211 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242929)
Source record
DIN 02242929: Apo-Warfarin
Raw flags: sec3=Y
Item: 201200008; group id 263; item number 0530; lccId None; manufacturer id APX
Source form: Tab; strength: 10mg
Recorded listing: General benefit
Source prices (unrounded): $0.1211; ministry $0.1211
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242929
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66767
Interchangeable products
Coumadin · DIN 01918362 · not recorded
Taro-Warfarin · DIN 02242687 · $0.1211
Shortage status: resolved shortage (ended June 19, 2020); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242929
Shortage record checked October 6, 2026
Taro-Warfarin · DIN 02242687 · 10 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Taro-Warfarin · DIN 02242687
Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07
Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 10 MG · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTaro-Warfarin: Formulary list price $0.12 per unit (the source does not state the unit; exact figure $0.1211). What the ministry pays, not the patient.
Ministry pays: $0.1211 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242687)
Source record
DIN 02242687: Taro-Warfarin
Raw flags: sec3=Y
Item: 201200008; group id 263; item number 0530; lccId None; manufacturer id TAR
Source form: Tab; strength: 10mg
Recorded listing: General benefit
Source prices (unrounded): $0.1211; ministry $0.1211
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242687
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66477
Interchangeable products
Apo-Warfarin · DIN 02242929 · $0.1211
Coumadin · DIN 01918362 · not recorded
Shortage status: resolved shortage (ended March 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242687
Shortage record checked October 6, 2026
Taro-Warfarin · DIN 02242686 · 6 mg · tablet
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked November 18, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Taro-Warfarin · DIN 02242686
Manufacturer: Taro Pharmaceuticals Inc.; listing date 2008-12-03
Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 6 MG · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordFormulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242686)
Source record
DIN 02242686: Taro-Warfarin
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 201200077; group id 263; item number 0529; lccId None; manufacturer id TAR
Source form: Tab; strength: 6mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): $0.5160; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242686
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66476
Interchangeable products
Coumadin · DIN 02240206 · not recorded
Shortage status: resolved shortage (ended March 30, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242686
Shortage record checked October 6, 2026
Coumadin · DIN 01918311 · 1 mg · tablet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-30 — choose a marketed DIN from the same-category list.Discontinued June 30, 2020 · checked November 18, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-30 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-06-30 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Coumadin · DIN 01918311
Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01
Health Canada: Cancelled post market since 2020-06-30 · brand COUMADIN TAB 1MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 1 MG · company Lp food safety & sanitation / securite et sanitation alimentaire lp inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCoumadin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01918311)
Source record
DIN 01918311: Coumadin
Raw flags: notABenefit=Y, sec3=Y
Item: 201200026; group id 263; item number 0523; lccId None; manufacturer id BQU
Source form: Tab; strength: 1mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01918311
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12818
Interchangeable products
Apo-Warfarin · DIN 02242924 · $0.0796
Taro-Warfarin · DIN 02242680 · $0.0796
Shortage status: discontinued (August 31, 2020, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01918311
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since June 30, 2020 — choose a marketed DIN from the same-category list.
Coumadin · DIN 01918338 · 2 mg · tablet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-21 — choose a marketed DIN from the same-category list.Discontinued June 21, 2020 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-21 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-06-21 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Coumadin · DIN 01918338
Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01
Health Canada: Cancelled post market since 2020-06-21 · brand COUMADIN TAB 2MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2 MG · company Bristol-myers squibb canada · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCoumadin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01918338)
Source record
DIN 01918338: Coumadin
Raw flags: notABenefit=Y, sec3=Y
Item: 201200027; group id 263; item number 0524; lccId None; manufacturer id BQU
Source form: Tab; strength: 2mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01918338
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13536
Interchangeable products
Apo-Warfarin · DIN 02242925 · $0.0841
Taro-Warfarin · DIN 02242681 · $0.0841
Shortage status: discontinued (August 31, 2020, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01918338
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since June 21, 2020 — choose a marketed DIN from the same-category list.
Coumadin · DIN 01918346 · 2.5 mg · tablet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.Discontinued August 24, 2020 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Coumadin · DIN 01918346
Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01
Health Canada: Cancelled post market since 2020-08-24 · brand COUMADIN TAB 2.5MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2.5 MG · company Bristol-myers squibb canada · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCoumadin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01918346)
Source record
DIN 01918346: Coumadin
Raw flags: notABenefit=Y, sec3=Y
Item: 201200010; group id 263; item number 0525; lccId None; manufacturer id BQU
Source form: Tab; strength: 2.5mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01918346
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13419
Interchangeable products
Apo-Warfarin · DIN 02242926 · $0.0674
Taro-Warfarin · DIN 02242682 · $0.0674
Shortage status: discontinued (August 31, 2020, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01918346
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since August 24, 2020 — choose a marketed DIN from the same-category list.
Coumadin · DIN 02240205 · 3 mg · tablet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.Discontinued August 24, 2020 · checked November 18, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Coumadin · DIN 02240205
Manufacturer: Bristol Myers Squibb Canada Inc; listing date 2001-06-07
Health Canada: Cancelled post market since 2020-08-24 · brand COUMADIN TAB 3MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 3 MG · company Bristol-myers squibb canada · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCoumadin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02240205)
Source record
DIN 02240205: Coumadin
Raw flags: notABenefit=Y, sec3=Y
Item: 201200062; group id 263; item number 0526; lccId None; manufacturer id BQU
Source form: Tab; strength: 3mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02240205
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=63731
Interchangeable products
Apo-Warfarin · DIN 02245618 · $0.1043
Taro-Warfarin · DIN 02242683 · $0.1043
Shortage status: discontinued (August 31, 2020, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02240205
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since August 24, 2020 — choose a marketed DIN from the same-category list.
Coumadin · DIN 02007959 · 4 mg · tablet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.Discontinued June 25, 2020 · checked November 18, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Coumadin · DIN 02007959
Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01
Health Canada: Cancelled post market since 2020-06-25 · brand COUMADIN TAB 4MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 4 MG · company Texel une division de ads inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCoumadin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02007959)
Source record
DIN 02007959: Coumadin
Raw flags: notABenefit=Y, sec3=Y
Item: 201200028; group id 263; item number 0527; lccId None; manufacturer id BQU
Source form: Tab; strength: 4mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02007959
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13375
Interchangeable products
Apo-Warfarin · DIN 02242927 · $0.1043
Taro-Warfarin · DIN 02242684 · $0.1043
Shortage status: discontinued (June 15, 2020, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02007959
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since June 25, 2020 — choose a marketed DIN from the same-category list.
Coumadin · DIN 01918354 · 5 mg · tablet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-20 — choose a marketed DIN from the same-category list.Discontinued August 20, 2020 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-20 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-08-20 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Coumadin · DIN 01918354
Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01
Health Canada: Cancelled post market since 2020-08-20 · brand COUMADIN TAB 5MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 5 MG · company Bristol-myers squibb canada · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCoumadin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01918354)
Source record
DIN 01918354: Coumadin
Raw flags: notABenefit=Y, sec3=Y
Item: 201200035; group id 263; item number 0528; lccId None; manufacturer id BQU
Source form: Tab; strength: 5mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01918354
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12819
Interchangeable products
Apo-Warfarin · DIN 02242928 · $0.0675
Taro-Warfarin · DIN 02242685 · $0.0675
Shortage status: discontinued (August 10, 2020, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01918354
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since August 20, 2020 — choose a marketed DIN from the same-category list.
Coumadin · DIN 02240206 · 6 mg · tablet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.Discontinued June 25, 2020 · checked November 18, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Coumadin · DIN 02240206
Manufacturer: Bristol Myers Squibb Canada Inc; listing date 2008-06-27
Health Canada: Cancelled post market since 2020-06-25 · brand COUMADIN TAB 6 MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 6 MG · company Bristol-myers squibb canada · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCoumadin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02240206)
Source record
DIN 02240206: Coumadin
Raw flags: notABenefit=Y, sec3=Y
Item: 201200077; group id 263; item number 0529; lccId None; manufacturer id BQU
Source form: Tab; strength: 6mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02240206
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=63732
Interchangeable products
Taro-Warfarin · DIN 02242686 · not recorded
Shortage status: discontinued (July 10, 2020, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02240206
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since June 25, 2020 — choose a marketed DIN from the same-category list.
Coumadin · DIN 01918362 · 10 mg · tablet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-22 — choose a marketed DIN from the same-category list.Discontinued June 22, 2020 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-22 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-06-22 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Coumadin · DIN 01918362
Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01
Health Canada: Cancelled post market since 2020-06-22 · brand COUMADIN TAB 10MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 10 MG · company Bristol-myers squibb canada · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCoumadin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01918362)
Source record
DIN 01918362: Coumadin
Raw flags: notABenefit=Y, sec3=Y
Item: 201200008; group id 263; item number 0530; lccId None; manufacturer id BQU
Source form: Tab; strength: 10mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01918362
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13418
Interchangeable products
Apo-Warfarin · DIN 02242929 · $0.1211
Taro-Warfarin · DIN 02242687 · $0.1211
Shortage status: discontinued (June 1, 2020, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01918362
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since June 22, 2020 — choose a marketed DIN from the same-category list.
Other products in the same Health Canada class (B01A): coverage varies; not interchangeable
- Apixaban (Eliquis): general benefit
- Dabigatran etexilate (Pradaxa): general benefit, not a benefit
- Edoxaban (Lixiana): general benefit
- Enoxaparin (Noromby): general benefit
- Rivaroxaban (Xarelto): general benefit
- Dalteparin (Fragmin): limited Use 186, 187, 188, 189
5 more in the class list below
Other drugs in the same formulary class (20:12 Coagulants and Anti-Coagulants) and how they are covered
Matched class: 20:12 Coagulants and Anti-Coagulants
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Covered without a code on the Ontario formulary: APIXABAN, ENOXAPARIN, RIVAROXABAN
Some products covered without a code (check the product listing): DABIGATRAN ETEXILATE, EDOXABAN
20:12 Coagulants and Anti-Coagulants
· 38 products · General benefit · strengths: 2.5mg, 5mg · Tab
· 6 products · Off-Formulary Interchangeable, not an ODB benefit (2), General benefit (4) · strengths: 75mg, 110mg, 150mg · Cap
· 37 products · General benefit · strengths: 20mg/0.2mL, 30mg/0.3mL, 40mg/0.4mL, 60mg/0.6mL, 80mg/0.8mL, 120mg/0.8mL, 100mg/mL, 150mg/mL, 300mg/3mL · Inj Sol-0.2mL Pref Syr (Preservative-Free), Inj Sol-0.3mL Pref Syr (Preservative-Free), Inj Sol-0.4mL Pref Syr (Preservative-Free), Inj Sol-0.6mL Pref Syr (Preservative-Free), Inj Sol-0.8mL Pref Syr (Preservative-Free), Inj Sol-1mL Pref Syr (Preservative-Free), Inj Sol-3mL Vial Pk (With Preservative)
· 50 products · General benefit · strengths: 2.5mg, 10mg, 15mg, 20mg · Tab
· 10 products ·
Limited Use, codes 186, 187, 188, 189 · strengths: 3500IU/0.28mL, 7500IU/0.3mL, 2500IU/0.2mL, 5000IU/0.2mL, 10000IU/0.4mL, 12500IU/0.5mL, 15000IU/0.6mL, 18000IU/0.72mL, 16500IU/0.66mL, 25000IU/mL · Inj Pref Syr, Inj Pref Syr-0.66mL Pk, Multidose 3.8mL Pk
· 4 products ·
Limited Use, codes 378 (2), Off-Formulary Interchangeable, not an ODB benefit (2) · strengths: 2.5mg/0.5mL, 7.5mg/0.6mL · Inj Sol-Pref Syr 0.5mL Pk (Preservative Free), Inj Sol-Pref Syr 0.6mL Pk (Preservative Free)
· 7 products ·
Limited Use, codes 186, 187, 188, 189 · strengths: 9500IU/mL, 19000IU/mL · Pref Syr-0.3mL Pk, Pref Syr-0.4mL Pk, Pref Syr-0.6mL Pk, Pref Syr-0.8mL Pk, Pref Syr-1.0mL Pk
· 10 products · Off-Formulary Interchangeable, not an ODB benefit (5),
Limited Use, codes 441 (5) · strengths: 60mg, 90mg · Tab
· 11 products ·
Limited Use, codes 186, 187, 188, 189, 323 · strengths: 2500IU/0.25mL, 8000IU/0.4mL, 12000IU/0.6mL, 16000IU/0.8mL, 3500IU/0.35mL, 4500IU/0.45mL, 10000IU/0.5mL, 14000IU/0.7mL, 18000IU/0.9mL, 10000IU/mL, 20000IU/mL · Inj Pref Syr, Inj-2mL Pk
· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 0.75mg/mL, 2mg/mL · 100mL Vial Pk, 10mL Vial Pk
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 20:12
20:12:04 Direct Factor Xa Inhibitors
· 11 products · General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (3), General benefit (8) · strengths: 15mg, 30mg, 60mg · Tab
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 20:12:04
20:12:16 Hemostatics
· 5 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg · Tab
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 20:12:16
Full class listing
Related classes: 20:04 Antianemia Drugs, 20:16 Hematopoietic Agents, 20:24 Hemorrheologic Agents
Same formulary class, not same indication: class membership alone does not establish equivalent uses.
Availability
Apo-Warfarin · DIN 02242926
Shortage status: active shortage (reported 2024-05-28, last updated 2024-10-24) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242926
Check this DIN againTaro-Warfarin · DIN 02242683
Shortage status: discontinued (2021-11-25, reported by TARO PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242683
Check this DIN againTaro-Warfarin · DIN 02242685
Shortage status: discontinued (2023-09-22, reported by TARO PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242685
Check this DIN againCoumadin · DIN 01918311
Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01918311
Check this DIN againCoumadin · DIN 01918338
Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01918338
Check this DIN againCoumadin · DIN 01918346
Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01918346
Check this DIN againCoumadin · DIN 02240205
Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02240205
Check this DIN againCoumadin · DIN 02007959
Shortage status: discontinued (2020-06-15, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02007959
Check this DIN againCoumadin · DIN 01918354
Shortage status: discontinued (2020-08-10, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01918354
Check this DIN againCoumadin · DIN 02240206
Shortage status: discontinued (2020-07-10, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02240206
Check this DIN againCoumadin · DIN 01918362
Shortage status: discontinued (2020-06-01, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01918362
Check this DIN again